Condition: Asthma
Interventions: Drug: Lebrikizumab; Device: Prefilled Syringes
Sponsor: Hoffmann-La Roche
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Lebrikizumab; Device: Prefilled Syringes
Sponsor: Hoffmann-La Roche
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Lebrikizumab Asthma Market Analysis and Forecast to 2023
WhaTech Researcher has released its new PharmaPoint Drug Evaluation report, “Lebrikizumab (Asthma) – Forecast and Market Analysis to 2023?. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: lebrikizumnab; Other: placebo
Sponsor: Hoffmann-La Roche
Not yet recruiting – verified March 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting – verified June 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting – verified May 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Lebrikizumab Improves Lung Function in Asthma
Medscape August 4, 2011 — Treatment with the anti-interleukin-13 antibody lebrikizumab was associated with a significant improvement in lung function at week 12 compared to baseline in patients with poorly controlled asthma, according to the findings of a … Researchers find potential new treatment for asthma sufferers Lebrikizumab Ups Lung Function in Adults With Asthma IL-13 Blocker Helps Asthma Control |
View full post on asthma – Google News
Lebrikizumab Ups Lung Function in Adults With Asthma
Doctors Lounge Treatment with lebrikizumab increases lung function in adults with asthma, especially for those with high levels of serum periostin, according to a study published online Aug. 3 in the New England Journal of Medicine. THURSDAY, Aug. … IL-13 Blocker Helps Asthma Control Experimental Drug Promising Against Tough-to-Treat Asthma Roche Asthma Drug Meets Primary Endpoint In Phase II Study |
View full post on asthma – Google News